National French observatory of the quality of blood components for transfusion

Transfusion Clinique et Biologique

Volumn 15, Issue 3, 2008, Pages 85-90

  Chabanel, A ^a   Masse, M ^a   Begue, S ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Blood components; Haemoglobin content; Leucoreduction; Platelet additive solutions; Platelet content; Quality control; Residual leukocytes

Indexed keywords

HEMOGLOBIN; THROMBOCYTE CONCENTRATE;

APHERESIS; ARTICLE; BLOOD; BLOOD BANK; BLOOD COMPONENT; BLOOD TRANSFUSION; CELL SEPARATION; LEUKOCYTE; LEUKOCYTE COUNT; QUALITATIVE ANALYSIS; QUALITY CONTROL; THROMBOCYTE COUNT; TIME SERIES ANALYSIS;

BLOOD BANKS; BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; FRANCE; HEMOGLOBINS; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; PLATELET TRANSFUSION; QUALITY ASSURANCE, HEALTH CARE; SOLUTIONS;

EID: 47749107562     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.04.006     Document Type: Article

References (16)

1. Andreu G., Masse M., Royer D., and Tardivel R. Leukodepleted blood components: definition of a standard. Transfus Sci 19 (1998) 381-383
2. Arrêté du 30 mars 1998, Journal officiel de la République Française, 5 avril 1998, 5331-5333.
3. Arrêté du 29 avril 2003, Journal officiel de la République Française, 28 mai 2003, 9109-9140.
4. Chabanel A. Observatoire national de la qualité des PSL préparés par l'EFS. Transfus Clin Biol 14 (2007) 181
5. Chabanel A., Carrat F., Bégué S., Masse M., Perrault M.P., and Andreu G. Quality of leucoreduced red blood cell concentrates: 5 years of follow up in France. Vox Sang 94 (2008) 41-47
6. Andreu G., Vasse J., Hervé F., Tardivel R., and Semana G. Introduction of platelet additive solutions in transfusion practice: advantages, disadvantages and benefit for patients. Transfus Clin Biol 14 (2007) 100-106
7. Léauté A.G., and Le réseau des responsables du CQ des PSL. Évaluation externe de la qualité (EEQ) de la numération par cytométrie en flux des globules blancs (GB) résiduels dans les PSL. Transfus Clin Biol 14 (2007) 181-182
8. Dumont L.J., Dzik W.H., Rebulla P., Brandwein H., and The members of the BEST Working Party of the ISBT. Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the ISBT. Transfusion 36 (1996) 11-20
9. Tardivel R., Bois S., Massot D., and Semana G. Orbisac: un automate permettant d'améliorer et de standardiser la production des MCP. Transf Clin Biol 14 (2007) 213
10. Chabanel A., Andreu G., Carrat F., and Hervé P. Quality control of leucoreduced cellular blood components in France. Vox Sang 82 (2002) 67-71
11. Högman CF. What quality of red blood cells shall we offer the transfused patient? ISBT Science Series 2006; 1:120-126.
12. de Wildt-Eggen J., Nauta S., Schrijver J.G., van Marwijk Kooy M., Bins M., and Van Prooijen H.C. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective randomised study. Transfusion 40 (2000) 398-403
13. Ringwald J., Zimmermann R., and Eckstein R. The new generation of platelet additive solution for storage at 22 °C: development and current experience. Transfus Med Rev 20 (2006) 158-164
14. Gulliksson H. Platelet additive solutions: current status. Immunohematology 23 (2007) 14-19
15. Diedrich B., Sandgren P., Jansson B., Gulliksson H., Svensson L., and Shanwell A. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 94 (2008) 96-102
16. Cardigan R., Sutherland J., Garwood M., Bashir S., Turner C., Smith K., et al. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in Composol, PASII or 100% plasma in three different storage bags. Vox Sang 94 (2008) 103-112